Effect of miR-513a-5p on etoposide-stimulating B7-H1 expression in retinoblastoma cells

Abstract

This study investigated the effect of etoposide, an anticancer chemotherapy drug, on B7-H1 expression in retinoblastoma (Rb) cells and the role of miR-513a-5p in the process. Rb cells were divided into control and etoposide groups. In the etoposide group, cells were treated with etoposide at different concentrations (2.5, 5, 10, 20 and 40 μg/mL) for 24 h. Those given no treatment of etopside served as controls. Reverse transcription polymerase chain reaction (RT-PCR), fluorescence quantitative PCR and flow cytometry were performed to measure the mRNA and protein expression of B7-H1 in Rb cells. The mRNA expression of miR-513a-5p in Rb cells before and after etoposide treatment was also detected by fluorescence quantitative PCR. The miR-513a-5p mimics and the miR-513a-5p inhibitor were transfected into Rb cells separately, and fluorescence quantitative PCR and flow cytometry were used to detect the effect of the miR-513a-5p mimics or inhibitor on B7-H1 expression. TargetScan5.2 was employed to predict the miR-513a-5p binding sites in the 3′-untranslated region of B7-H1 mRNA. Luciferase reporter plasmids carrying this site were prepared and transfected into Rb cells and luciferase activity analyzed. The results showed that etoposide stimulated the mRNA and protein expression of B7-H1 in Rb cells, which reached a maximal level after treatment with 5 μg/mL etoposide (P<0.05). However, miR-513a-5p expression was decreased in Rb cells after etoposide treatment. When the miR-513a-5p inhibitor was added, B7-H1 expression was increased with the concentration of the miR-513a-5p inhibitor (P<0.05). Moreover, B7-H1 expression was decreased gradually with the concentration of the miR-513a-5p mimics increased (P<0.01). Additionally, the miR-513a-5p mimics were found to inhibit the luciferase activity. It was concluded that etoposide can promote B7-H1 expression in Rb cells, which may be associated with chemoresistance. The promoting effect of etoposide on B7-H1 expression can be reversed by miR-513a-5p mimics. MiR-513a-5p inhibits the mRNA and protein expression of B7-H1 via binding to the 3′-UTR of B7-H1 mRNA.

Keywords

miR-513a-5p / retinoblastoma / B7-H1

References

[1] AertsI., Lumbroso-Le RouicL., Gauthier-VillarsM., et al.. Retinoblastoma. Orphanet J Rare Dis, 2006, 1(9): 31

[2] SmythM.J., GodfreyD.I., TrapaniJ.A.. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol, 2001, 2(4): 293-299

[3] KhongH.T., RestifoN.P.. Natural selection of tumor variants in the generation of “tumor escape” phenotypes. Nat Immunol, 2002, 3(11): 999-1005

[4] DunnG.P., BruceA.T., IkedaH., et al.. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol, 2002, 3(11): 991-998

[5] DongH., ChenL.. B7-H1 pathway and its role in the evasion of tumor immunity. J Mol Med (Berl), 2003, 81(5): 281-287

[6] HwangH.W., MendellJ.T.. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer, 2006, 94(6): 776-780

[7] MetzlerM., WildaM., BuschK., et al.. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer, 2004, 39(2): 167-169

[8] CalinG.A., FerracinM., CimminoA., et al.. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med, 2005, 353(17): 1793-1801

[9] BartelD.P.. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2): 281-297

[10] GongA.Y., ZhouR., HuG., et al.. MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes. J Immunol, 2009, 182(3): 1325-1333

[11] MuhlbauerM., FleckM., SchutzC., et al.. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J Hepatol, 2006, 45(4): 520-528

[12] CurielT.J., WeiS., DongH., et al.. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med, 2003, 9(5): 562-567

[13] AzumaT., YaoS., ZhuG., et al.. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood, 2008, 111(7): 3635-3643

[14] UsuiY., OkunukiY., HattoriT., et al.. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1. Invest Ophthalmol Vis Sci, 2006, 47(10): 4607-4613